$26.30
1.54% yesterday
NYSE, Feb 21, 10:13 pm CET
ISIN
US7170811035
Symbol
PFE
Sector
Industry

Pfizer Stock price

$26.30
-0.34 1.28% 1M
-2.73 9.40% 6M
-0.23 0.87% YTD
-1.37 4.95% 1Y
-22.23 45.81% 3Y
-7.54 22.28% 5Y
-6.28 19.27% 10Y
NYSE, Closing price Fri, Feb 21 2025
+0.40 1.54%
ISIN
US7170811035
Symbol
PFE
Sector
Industry

Key metrics

Market capitalization $149.04b
P/E (TTM) P/E ratio 18.68
P/S ratio (TTM) P/S ratio 2.34
P/B ratio (TTM) P/B ratio 1.61
Dividend yield 6.53%
Last dividend (FY24) $1.69
Revenue growth (TTM) Revenue growth 8.77%
Revenue (TTM) Revenue $63.63b
EBIT (operating result TTM) EBIT $14.59b
Cash position $9.95b
EPS (TTM) EPS $1.41
P/E forward 15.80
P/S forward 2.35
EV/Sales forward 3.27
Short interest 1.30%
Show more

Is Pfizer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,815 stocks worldwide.

Pfizer Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Pfizer forecast:

10x Buy
42%
13x Hold
54%
1x Sell
4%

Analyst Opinions

24 Analysts have issued a Pfizer forecast:

Buy
42%
Hold
54%
Sell
4%

Financial data from Pfizer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
63,627 63,627
9% 9%
100%
- Direct Costs 22,261 22,261
25% 25%
35%
46,588 46,588
63% 63%
73%
- Selling and Administrative Expenses 16,018 16,018
96% 96%
25%
- Research and Development Expense 10,756 10,756
2% 2%
17%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 14,592 14,592
305% 305%
23%
Net Profit 8,027 8,027
276% 276%
13%

In millions USD.

Don't miss a Thing! We will send you all news about Pfizer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pfizer Stock News

Positive
The Motley Fool
about 17 hours ago
Looking for a good area in which to invest? Consider the healthcare sector.
Negative
Reuters
one day ago
Pfizer will end global development of its bleeding disorder gene therapy, Beqvez, the Nikkei reported on Thursday.
Positive
Seeking Alpha
one day ago
The S&P 500 is up 3.96% YTD, and I predict it could reach 7,000 by the end of 2025. The Dividend Harvesting Portfolio reached a new milestone with a 28.65% ROI, generating $2,010.09 in forward annualized dividend income. I added to positions in Pfizer, Starwood Property Trust, and Reaves Utility Income Trust, focusing on undervalued stocks with strong dividend yields.
More Pfizer News

Company Profile

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Head office United States
CEO Albert Bourla
Founded 1849
Website www.pfizer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today